These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8181022)

  • 1. Prevention of heart failure and postinfarction remodeling.
    Deedwania PC
    Cardiol Clin; 1994 Feb; 12(1):155-64. PubMed ID: 8181022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling.
    Abbate A; Biondi-Zoccai GG; Baldi A
    J Cell Physiol; 2002 Nov; 193(2):145-53. PubMed ID: 12384991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dog model of left ventricular remodeling after myocardial infarction.
    Jugdutt BI
    J Card Fail; 2002 Dec; 8(6 Suppl):S472-5. PubMed ID: 12555160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure post-myocardial infarction: a review of the issues.
    Dargie H
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii3-6; discussion ii31, ii43-8. PubMed ID: 15831607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular remodeling in heart failure.
    Gaballa MA; Goldman S
    J Card Fail; 2002 Dec; 8(6 Suppl):S476-85. PubMed ID: 12555161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postinfarction cardiac remodeling--clinical consequences].
    Karpiński Ł; Witkowska M
    Przegl Lek; 2009; 66(7):380-3. PubMed ID: 20043580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE; Konstam MA
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A catheter based chronic porcine model of post-infarct dilated heart failure.
    Brødløs HK; Bramsen MB; Agger P; Jensen H; Bjerre M; Ringgaard S; Wierup P; Nielsen SL; Hasenkam JM; Smerup M
    Scand Cardiovasc J; 2009 Aug; 43(4):260-6. PubMed ID: 19065447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia/Infarction.
    Jugdutt BI
    Heart Fail Clin; 2012 Jan; 8(1):43-51. PubMed ID: 22108726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.